We are live on ! Find out more
CC

Clearline Capital Portfolio holdings

AUM $1.93B
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
-6.92%
1 Year Est. Return
+38.13%
3 Year Est. Return
+17.96%
5 Year Est. Return
-8.68%
10 Year Est. Return
-18.93%
AUM
$1.16B
AUM Growth
-$561M
Cap. Flow
-$498M
Cap. Flow %
-42.76%
Top 10 Hldgs %
40.07%
Holding
149
New
35
Increased
35
Reduced
29
Closed
24

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$38.4M
2
WTW icon
Willis Towers Watson
WTW
+$33.3M
3
MASI
Masimo
MASI
+$32.1M
4
ALIT icon
Alight
ALIT
+$23.1M
5
AMD icon
Advanced Micro Devices
AMD
+$22.8M

Top Sells

Rank Stock Value
1
DELL icon
Dell
DELL
+$13.1M
2
BCO icon
Brink's
BCO
+$12.3M
3
SPB icon
Spectrum Brands
SPB
+$11M
4
SMTC icon
Semtech
SMTC
+$10.5M
5
VYX icon
NCR Voyix
VYX
+$9.61M

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 21.58%
3 Consumer Discretionary 9.68%
4 Consumer Staples 8.66%
5 Communication Services 7.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLNG icon
76
Golar LNG
GLNG
$4.95B
$3.04M 0.26%
125,113
+8,900
+8% +$205K
XMTR icon
77
Xometry
XMTR
$4.58B
$2.94M 0.25%
+173,109
New +$3.28M
SEAT icon
78
Vivid Seats
SEAT
$88.7M
$2.87M 0.25%
22,347
+698
+3% +$103K
COOP
79
DELISTED
Mr. Cooper
COOP
$2.5M 0.21%
46,607
-45,664
-49% -$2.51M
PLYA
80
DELISTED
Playa Hotels & Resorts
PLYA
$2.38M 0.2%
329,345
PTON icon
81
Peloton Interactive
PTON
$2.84B
$2.33M 0.2%
461,656
-48,798
-10% -$347K
COLL icon
82
Collegium Pharmaceutical
COLL
$1.16B
$2.27M 0.19%
101,498
+8,754
+9% +$200K
MRTX
83
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.23M 0.19%
51,275
-5,066
-9% -$181K
LGTY
84
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$2.2M 0.19%
191,982
GTM
85
ZoomInfo Technologies
GTM
$967M
$2.19M 0.19%
+133,818
New +$2.73M
EB
86
DELISTED
Eventbrite
EB
$2.11M 0.18%
214,440
PINC
87
DELISTED
Premier
PINC
$2.03M 0.17%
94,448
TALK icon
88
Talkspace
TALK
$873M
$2M 0.17%
1,027,709
MNRO icon
89
Monro
MNRO
$537M
$1.98M 0.17%
+71,292
New +$2.46M
BLMN icon
90
Bloomin' Brands
BLMN
$736M
$1.98M 0.17%
+80,320
New +$2.13M
SWI
91
DELISTED
SolarWinds Corporation Common Stock
SWI
$1.89M 0.16%
200,113
+43,294
+28% +$455K
SFIX
92
Stitch Fix
SFIX
$563M
$1.82M 0.16%
528,807
BLKB icon
93
Blackbaud
BLKB
$1.65B
$1.78M 0.15%
25,301
-24,301
-49% -$1.79M
HAS icon
94
Hasbro
HAS
$13.6B
$1.71M 0.15%
+25,792
New +$1.71M
EEFT icon
95
Euronet Worldwide
EEFT
$3.15B
$1.69M 0.15%
+21,308
New +$1.98M
EHAB
96
DELISTED
Enhabit
EHAB
$1.61M 0.14%
143,344
+88,475
+161% +$1.11M
TXMD icon
97
TherapeuticsMD
TXMD
$23.8M
$1.38M 0.12%
455,388
+16
+0% +$61
VTRS icon
98
Viatris
VTRS
$20.8B
$1.3M 0.11%
131,941
UAA icon
99
Under Armour
UAA
$3.04B
$1.26M 0.11%
+183,728
New +$1.38M
SPRY icon
100
ARS Pharmaceuticals
SPRY
$563M
$1.03M 0.09%
271,678
+210,576
+345% +$1.38M

Similar funds

Clearline Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Clearline Capital held 149 positions worth $1.16B, down 32% from $1.73B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Clearline Capital withdrew a net $498M in Q3 2023, closing 24 positions and reducing 29 holdings. Its most notable exit was Dell, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Clearline Capital opened a new position in Kenvue worth $33.3M.

  • Clearline Capital's largest Q3 2023 buy was Kenvue: 1,659,887 shares worth $33.3M.
  • Clearline Capital added most to Alight in Q3 2023, an estimated $23.1M increase.
  • Clearline Capital's biggest Q3 2023 reduction was Brink's, cutting an estimated $12.3M.
  • Clearline Capital fully exited Dell in Q3 2023, selling an estimated $13.1M.
  • Clearline Capital's ten largest holdings make up 40% of its $1.16B portfolio in Q3 2023.
  • Clearline Capital opened 35 new positions and closed 24 in Q3 2023.
  • Clearline Capital's portfolio value fell 32% quarter-over-quarter to $1.16B.

Based on Clearline Capital's 13F filing for Q3 2023, filed 14 Nov 2023.